Multiple studies show that administration of AT1R blockers (ARBs), such as losartan and candesartan, rescues neuroinflammation, oxidative stress, and improves cognitive impairment; thus, AT1R activation may accelerate neurodegeneration [46–48]. This evidence concerns the gene AGTR1 and Cognitive impairment.